About the Company

FarsiPharm™ trademark presents products of Iran pharmaceutical plants group company.

Group company's business priorities are to ensure high quality of produced pharmaceutical drugs. This is achieved by using high-quality raw materials when making pharmaceutical drugs. Suppliers of raw materials are famous companies Fujisawa, Daichi (Japan), Sandoz International (Germany), Farmhispania, UQUIFA (Spain) etc. Manufactured products are improved owing to rationalization and modification of production technologies. Plants are fitted with up-to-date equipment made by BOSCH (Germany). The enterprises often conduct studies of released generic pharmaceutical drugs bioequivalence. All production processes meet the requirements of GMP branch standard and the requirements of ISO series standards.

OUR CAPABILITIES:

Product registration. We professionally and promptly prepare registration package with packing graphic design models for carrying out registration (reregistration) procedure of pharmaceutical drugs, medical products and dietary supplements.

Product promotion. Staff of experienced and professional medical representatives makes direct communication with doctors and employees of pharmacy institutions providing them with comprehensive information on the pharmacological properties of medications and practical use.

Participation in scientific and practical events. We regularly participate in scientific and practical conferences, exhibitions, communities both at regional and national levels.

Production of POS-materials. We develop and produce POS-materials for promoted products: booklets, leaflets, souvenirs and other product types.

Distribution. OJSC Medvestsnab is an official distributor for FarsiPharm trademark products on the territory of Ukraine.

FarsiPharm trademark provides high level of services:

  • a unique experience at Ukraine's pharmaceutical market since 2003;
  • a wide product range;
  • definite criteria of performance, efficiency and economy;
  • successful results of cooperation with leaders of national pharmaceutical product distribution.

Feedback form